- Home
- GTE vs ELDN Comparison
GTE vs ELDN Comparison
Compare GTE & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTE
- ELDN
- Stock Information
- Founded
- GTE 2003
- ELDN 2004
- Country
- GTE Canada
- ELDN United States
- Employees
- GTE N/A
- ELDN N/A
- Industry
- GTE Oil & Gas Production
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- GTE Energy
- ELDN Health Care
- Exchange
- GTE Nasdaq
- ELDN Nasdaq
- Market Cap
- GTE 164.0M
- ELDN 178.4M
- IPO Year
- GTE N/A
- ELDN N/A
- Fundamental
- Price
- GTE $4.56
- ELDN $2.89
- Analyst Decision
- GTE
- ELDN Strong Buy
- Analyst Count
- GTE 0
- ELDN 1
- Target Price
- GTE N/A
- ELDN $16.00
- AVG Volume (30 Days)
- GTE 193.9K
- ELDN 160.2K
- Earning Date
- GTE 05-01-2025
- ELDN 05-20-2025
- Dividend Yield
- GTE N/A
- ELDN N/A
- EPS Growth
- GTE N/A
- ELDN N/A
- EPS
- GTE N/A
- ELDN N/A
- Revenue
- GTE $634,805,000.00
- ELDN N/A
- Revenue This Year
- GTE $10.77
- ELDN N/A
- Revenue Next Year
- GTE N/A
- ELDN N/A
- P/E Ratio
- GTE N/A
- ELDN N/A
- Revenue Growth
- GTE N/A
- ELDN N/A
- 52 Week Low
- GTE $3.34
- ELDN $2.00
- 52 Week High
- GTE $10.40
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- GTE 52.99
- ELDN 40.93
- Support Level
- GTE $3.99
- ELDN $2.85
- Resistance Level
- GTE $4.56
- ELDN $3.51
- Average True Range (ATR)
- GTE 0.21
- ELDN 0.27
- MACD
- GTE 0.02
- ELDN -0.01
- Stochastic Oscillator
- GTE 70.62
- ELDN 5.63
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.